MedTrace Logo

Topical Ketamine Analgesia in Children Undergoing Tonsillectomy: a Clinical and Serum Level Assays Study.

NCT02720406 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-06-07

No results posted yet for this study

Summary

The aim of this study is to evaluate the analgesia efficacy of local ketamine given by two different doses in pediatric patients undergoing tonsillectomy operations

Conditions

  • Postoperative Pain

Interventions

DRUG

Intravenous ketamine0.5mg/kg

Intravenous ketamine 0.5mg/kg after anesthesia and before surgery.

DRUG

Nebulized Ketamine 1mg/kg

Nebulized Ketamine 1mg/kg given by nebulizer before anesthesia.

DRUG

Nebulized Ketamine 2mg/kg

Nebulized Ketamine 2mg/kg given by nebulizer before anesthesia.

DRUG

saline placebo

Saline 0.9% given by nebulizer before anesthesia and iv after anesthesia and before surgery.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Hala S Abdel-Ghaffar, MD · Assisstant professor in anesthesia and intensive care, faculty of medicine, Assiut university, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02720406 on ClinicalTrials.gov